AVITA Medical (ASX:AVH) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 09, 2026)


ASX:AVH AVITA Medical Inc ASX:AVH
60 GF Score
Price A$1.34
GF Value A$3.26
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is AVITA Medical 5-Year Yield-on-Cost %?

AVITA Medical ASX:AVH -4.64% 60 5-Year Yield-on-Cost % is 0.00 as of Jul. 09, 2026. GuruFocus rates ASX:AVH with a GF Score™ of 60/100 and a GF Value™ of A$3.26 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 327 Medical Devices & Instruments companies, AVITA Medical ranks worse than 305810.09% on this metric.

AVITA Medical's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for AVITA Medical's 5-Year Yield-on-Cost % or its related term are showing as below:



ASX:AVH's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.39
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

AVITA Medical  (ASX:AVH) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


AVITA Medical 5-Year Yield-on-Cost % Related Terms


ASX:AVH vs MXCT, HYPR, ZOMDF: 5-Year Yield-on-Cost % Comparison

For the Medical Devices subindustry, AVITA Medical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVITA Medical 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where AVITA Medical's 5-Year Yield-on-Cost % falls into.


ASX:AVH
60GF Score
AVITA Medical Inc ASX:AVH
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AVITA Medical 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of AVITA Medical is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
AVITA Medical (ASX:AVH) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on AVITA Medical and its competitors. According to the industry distribution chart, AVITA Medical ranks #999999 out of 327 companies in the Medical Devices & Instruments industry.
Is AVITA Medical's 5-Year Yield-on-Cost % too high?
AVITA Medical's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, AVITA Medical ranks #999999 out of 327 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, AVITA Medical has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AVITA Medical's 5-Year Yield-on-Cost % compare to MXCT and HYPR?
According to the Medical Devices & Instruments industry distribution chart, AVITA Medical ranks #999999 out of 327 companies for 5-Year Yield-on-Cost %. This places AVITA Medical in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.39, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on AVITA Medical and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AVITA Medical's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVITA Medical stock overvalued right now?
Based on GuruFocus' analysis, AVITA Medical (ASX:AVH) is currently considered Possible Value Trap. The stock's GF Value™ is A$3.26, compared to a current price of A$1.34 — trading 59% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. AVITA Medical's overall GF Score™ is 60/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For AVITA Medical (ASX:AVH), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AVITA Medical (ASX:AVH) Overvalued in 2026?

Based on GuruFocus' analysis, AVITA Medical stock appears to be undervalued. The current stock price of A$1.34 is trading 59% below its estimated GF Value™ of A$3.26. GuruFocus considers AVITA Medical to be Possible Value Trap.

Key valuation signals for ASX:AVH:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: A$3.26 vs. price of A$1.34 (59% below fair value)
  • GF Score™: 60/100 with 7 warning signs

No single metric tells the full story. See the ASX:AVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AVITA Medical Business Description

Address 28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
60GF Score

Get the complete analysis for ASX:AVH

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.34
Price
A$3.26
GF Value